Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Viking Therapeutics (VKTX) over the last 12 years, with Q3 2025 value amounting to $712000.0.

  • Viking Therapeutics' Non-Current Assets fell 4253.43% to $712000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year decrease of 2459.39%. This contributed to the annual value of $1.1 million for FY2024, which is 1264.82% down from last year.
  • Viking Therapeutics' Non-Current Assets amounted to $712000.0 in Q3 2025, which was down 4253.43% from $834000.0 recorded in Q2 2025.
  • Over the past 5 years, Viking Therapeutics' Non-Current Assets peaked at $1.7 million during Q1 2022, and registered a low of $134000.0 during Q4 2021.
  • For the 5-year period, Viking Therapeutics' Non-Current Assets averaged around $1.0 million, with its median value being $1.2 million (2024).
  • As far as peak fluctuations go, Viking Therapeutics' Non-Current Assets crashed by 6844.83% in 2021, and later skyrocketed by 101119.4% in 2022.
  • Over the past 5 years, Viking Therapeutics' Non-Current Assets (Quarter) stood at $134000.0 in 2021, then surged by 1011.19% to $1.5 million in 2022, then decreased by 15.04% to $1.3 million in 2023, then decreased by 12.65% to $1.1 million in 2024, then tumbled by 35.57% to $712000.0 in 2025.
  • Its last three reported values are $712000.0 in Q3 2025, $834000.0 for Q2 2025, and $970000.0 during Q1 2025.